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Bone marrow-derived monocyte lineage cells recruited
by MIP-1b promote physiological revascularization in
mouse model of oxygen-induced retinopathy
Keijiro Ishikawa1, Shigeo Yoshida1, Shintaro Nakao1, Yukio Sassa1, Ryo Asato1, Riichiro Kohno1, Mitsuru Arima1,
Takeshi Kita1, Ayako Yoshida1, Kenoki Ohuchida2 and Tatsuro Ishibashi1
Recent clinical observations have indicated that vascular endothelial growth factor (VEGF) is a key factor that
stimulates the development of preretinal pathological neovascularization (NV). However, it has not been established how
intraretinal physiological revascularization of hypoxic avascular areas is regulated. Our earlier study on the gene
expression profile of hypoxic retinas in a mouse model of oxygen-induced retinopathy (OIR) showed that macrophage
inflammatory protein-1b (MIP-1b) was the most upregulated protein. The purpose of this study was to investigate the role
played by MIP-1b in recruiting bone marrow-derived monocyte lineage cells (BM-MLCs) in a mouse model of OIR. Our
results showed that MIP-1b was upregulated, and its receptor, CCR5, was expressed in BM-MLCs in the hypoxic inner
retina. Neutralizing Ab against MIP-1b reduced the infiltration of BM-MLCs into the OIR retinas and increased the
avascular area and preretinal neovascular tufts. A very strong significant correlation was found between the area of the
preretinal neovascular tufts and the avascular area, regardless of the extent of BM-MLC infiltration into the OIR retinas.
Additional treatment with VEGF-A-neutralizing Ab showed that the MIP-1b-regulated pathological NV strongly depended
on VEGF-A, which was probably secreted by the hypoxic avascular retinas. These results indicate that MIP-1b is involved in
the recruitment of BM-MLCs, which have a significant role in the physiological revascularization of hypoxic avascular
retinas. Overall, these findings indicate that the MIP-1b induction of BM-MLCs might possibly be used to promote
intraretinal revascularization and thus prevent the abnormal NV in ischemic vision-threatening retinal diseases.
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Tissue hypoxia is believed to be the common mechanism that
initiates a series of events leading to compensatory angio-
genesis. Hypoxia-induced retinal neovascularization (NV) is
the main contributor to proliferative vascular diseases, such
as diabetic retinopathy, retinopathy of prematurity, and ret-
inal vein occlusion. These diseases can lead to irreversible
damage to visual function.
To determine the factors that are activated during retinal
hypoxia, we performed a gene expression profile of hypoxic
retinas obtained from a mouse model of oxygen-induced
retinopathy (OIR) using gene microarray analyses. The re-
sults identified the functional set of genes that are related to
the post-ischemic inflammation, neural and vascular devel-
opment, and subsequent pathological NV. The most upre-
gulated gene among the differentially expressed genes in
hypoxic retinas was the macrophage inflammatory protein-
1b (MIP-1b) and not vascular endothelial growth factor A
(VEGF-A) and other chemokines.1
MIP-1b, also known as chemokine CC motif ligand 4, is a
member of the CC chemokine family that are characterized
by their ability to direct migration of leukocytes into in-
flamed tissues.2 MIP-1b was first isolated from the culture
medium of LPS-activated macrophages,3 and it recruited
macrophages/microglia to the sites of injury in patients with
arthritis,4 sepsis,5 and systemic sclerosis.6
The upregulation of MIP-1b in the ischemic retina has
been shown to occur in an ischemia–reperfusion injury
model,7 and its receptor, CCR5, is involved in the
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development of corneal NV.8 However, it is not known what
role the MIP-1b/CCR5 system has in the hypoxia-induced
retinal NV.
There are two types of hypoxia-induced retinal NV;
one is pathological NV with a sprouting of abnormal
vessels from the retina into the vitreous, and the other is
physiological revascularization of avascular areas with func-
tional intraretinal vasculature. Recent experimental and
clinical studies have shown that VEGF-A is a key factor
in the development of pathological NV, and VEGF-A in-
hibitory drugs can inhibit the pathological NV, including
those associated with retinal diseases.9,10 However, the clin-
ical use of VEGF-A inhibitors showed that these drugs can
also enhance tissue hypoxia that would then damage
the tissue.11,12
Little information is available on how physiological re-
vascularization of hypoxic avascular retinas is regulated. Bone
marrow-derived monocyte lineage cells (BM-MLCs) are im-
portant angiogenic effector cells that produce a number of
proangiogenic factors.13 The role played by proangiogenic
BM-MLCs in hypoxia-induced retinal NV has been discussed
mainly in the process of pathological NV.14 It has been
suggested that the SDF1/CXCR4 system might be involved in
the recruitment of these cells into hypoxic retinas.15
The ability of the retina to respond to hypoxia by phy-
siological revascularization suggests that this property of the
retina might be used in the treatment of ischemic retino-
pathy. In this process, BM-MLCs would facilitate the phy-
siological revascularization in the hypoxic areas.16 However,
little is known on the mechanism that recruits these cells into
hypoxic retinas.
Thus, the purpose of this study was to investigate the role
played by the MIP-1b/CCR5 system in hypoxia-induced
retinal NV. We shall show that BM-MLCs promoted in-
traretinal revascularization in hypoxic avascular retina. The
possible biological role played by BM-MLCs in the formation
of intraretinal revascularization is discussed.
MATERIALS AND METHODS
Mouse Model of OIR
All experimental procedures on the animals were performed
according to the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals in Oph-
thalmic and Vision Research. OIR was induced in C57BL/6J
mice as described in detail by Smith et al.17 Briefly, litters of
postnatal day 7 (P7) C57BL/6J pups along with their mothers
were placed in a 75±2% oxygen atmosphere (hyperoxia) for
5 days and then returned to room air at age P12. After the
pups were returned to room air and the avascular areas of
retina became hypoxic, intraretinal physiological revascular-
ization of the avascular areas and preretinal pathological NV
developed simultaneously. Pathological NV reached its
maximum at P17. Mice were killed by cervical dislocation,
and the eyes were enucleated.
RNA Isolation and Real-Time Quantitative Reverse
Transcription–Polymerase Chain Reaction
Whole retinas free of vitreous were isolated from normal P12
and hyperoxic mice before returning them to room air. Other
mice were kept in room air for 3, 6, 12 h, and 1, 2, 3, and 5
days (relative hypoxia) before the retinas were isolated. Two
retinas from one mouse were pooled, and three experiments
for each condition (biological replicates) were examined.
RNA isolation and real-time quantitative reverse transcrip-
tion–polymerase chain reaction (qRT-PCR) were performed
as described.1 The primers were as follows: for Mip-1b,
50-CCATGAAGCTCTGCGTGTCTG-30 and 50-GGCTTGGAG
CAAAGACTGCTG-30; for F4/80, 50-CGCTGCTGGTTGA
ATACAGAGA-30 and 50-CGGTTGAGCAGACAGTGAATG
A-30; for Vegfa, 50-GGAGAGCAGAAGTCCCATGA-30 and
50-ACTCCAGGGCTTCATCGTTA-30; and for GAPDH, 50-GT
GAAGGTCGGTGTGAACGG-30 and 50-TCTCCATGGTGGT
GAAGACA-30.
Enzyme-Linked Immunosorbent Assay
Whole retinas free of vitreous were isolated from normal P12
mice, hyperoxic mice P12 mice, and from mice after 6, 12 h,
and 1, 2, 3, and 5 days of relative hypoxia. Four retinas from
two mice raised under the same conditions were pooled, and
three experiments for each condition (biological replicates)
were examined. Protein was isolated as described.1 An ELISA
kit (R&D Systems, Minneapolis, MN) was used to measure
the concentrations of MIP-1b according to the manu-
facturers’ instructions. The minimum concentration of MIP-
1b that could be detected was 6.0 pg/ml. The concentration of
total protein was determined with a commercial assay kit
(Bio-Rad protein assay reagent kit; Bio-Rad Laboratories,
Hercules, CA).
Microdissection-Based Quantitative Analysis of mRNA
The retinal layers were dissected by laser capture micro-
dissection (LCM) to analyze the MIP-1b expression in the
retinal ganglion cell layer (GCL), inner nuclear layer (INL),
and outer nuclear layer (ONL). Frozen eyes of P12 and
P12þ 12-h control mice, P12 hyperoxia-exposed mice, and
mice at 12 h after relative hypoxia were cut into 8-mm thick
sections. The GCL, INL, and ONL in the retinas at each time
were isolated selectively using LCM and a pressure cata-
pulting system (LMPC; Palm Microlaser Technologies AG,
Bernried, Germany) in accordance with the manufacturer’s
protocols. After microdissection, the total RNA was extracted
from the selected cells as described,18 and real-time qRT-PCR
for MIP-1b was performed on the RNA. The results were
normalized to the level of GAPDH expression.
Immunohistochemistry of Retina
Immunohistochemistry was performed as described.19 The
eyes of hypoxic P14 mice and normoxic P14 mice were
enucleated and fixed in 4% paraformaldehyde (PFA) and
then embedded in paraffin. Sections (3 mm) were rehydrated
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and incubated for 1 h at room temperature with anti-MIP-1b
antibody (1:500 dilution; R&D Systems, Minneapolis, MN)
or antibody against VEGF (1:100 dilution; Santa Cruz Bio-
chemicals, Santa Cruz, CA) with 1% skim milk. The bound
Ab was made visible by a conventional avidin–biotin perox-
idase protocol with 3-amino-9-ethylcarbazole as the sub-
strate. For negative controls, mouse nonimmune IgG was
used as the primary Ab.
Immunofluorescent Staining
For FITC-dextran angiography, animals were anesthetized by
an intraperitoneal injection of sodium pentobarbital, and
approximately 500 ml of FITC-dextran (50mg/ml; Sigma-
Aldrich, St Louis, MO) was injected into the left ventricle.
The dextran was allowed to circulate for approximately 2min
before the animals were euthanatized and the eyes
enucleated. Immunofluorescent staining was done for the
following: F4/80, a marker for monocyte lineage cells; CCR5,
the sole receptor for MIP-1b ligand; and CD45, a marker
commonly used to identify BM-derived cells20 on P17 OIR
retinas. After the eyes were enucleated, the cornea, iris, and
sclera were removed leaving the retina around the lens. After
an initial fixation in 4% PFA for 1 h at 4 1C, the lens was
removed. The whole retinas were then fixed in the same
fixative for an additional 21 h at 4 1C. Fixed samples were
rinsed with phosphate-buffered saline (PBS) and placed in
100% methanol at room temperature for 10min. The sam-
ples were blocked using 5% skim milk in PBS for 1 h at room
temperature, and then incubated in primary Abs at 4 1C for
24 h and then in the secondary Ab for 1 h at room tem-
perature. Radial cuts were made in the retinas, and the retinas
were flat-mounted in Crystal/Mount (Biomedia, Foster City,
CA). The retinas were examined by fluorescent microscopy
(BZ-9000; KEYENCE, Osaka, Japan).
The primary Abs were F4/80 (1:1000 dilution, rat IgG;
eBIOSCIENCE, San Diego, CA, USA), rabbit/anti-mouse
CCR5 Ab (1:1000 dilution, rabbit IgG; Abcam, Cambridge,
MA, USA), and anti-mouse CD45-cy5 Ab (1:1000 dilution;
Abcam). The secondary Abs were AlexaFluor546 (1:800 di-
lution, chicken anti-rat IgG; Molecular Probes), Alexa-
Fluor647 (1:800 dilution, goat anti-rabbit IgG; Molecular
Probes), AlexaFluor488 (1:800 dilution, chicken anti-rabbit
IgG; Molecular Probes), and AlexaFluor546 (1:800 dilution,
goat anti-rat IgG; Molecular Probes).
Intravitreal Injections
Mice were deeply anesthetized by an intraperitoneal injection
of sodium pentobarbital. The closed lids were separated, and
the eyes were proptosed. Intravitreal injections were per-
formed on P12 and P14 pups by injecting 1.0 ml of the agents
into the eyes with a 32-gauge needle on a Hamilton syringe.
The needle was inserted 200 mm posterior to the limbus. For
combined injections of anti-MIP-1b and anti-VEGF164 Ab,
anti-MIP-1b Ab was injected into P12 pups and 1.0 ml of
premixed Abs (50 ng/0.5 ml each) was injected into P14 pups.
The agents were neutralizing Ab against MIP-1b (100 ng/ml;
R&D Systems) and neutralizing Ab against VEGF164 (100 ng/
ml; R&D Systems). Nonimmune IgG was used as controls.
Quantification of F4/80 mRNA Expression and F4/80
Positive Cells
Retinas were dissected from P17 OIR pups after the injections
of the different agents, and RNA analysis and immuno-
fluorescent staining were performed as described. To quantify
the relative mRNA expression of F4/80 normalized to
GAPDH, real-time qRT-PCR was performed on MIP-1b
antibody-treated retinas (n¼ 6) and nonimmune IgG-treated
controls (n¼ 6). To quantify the F4/80-positive cells in P17
OIR flat-mounted retinas, photographs were taken at  4
magnification (4 images/retina), and the F4/80-positive cells
were counted in the digital images in a masked manner
(MIP-1b Ab, n¼ 8; control, n¼ 8).
Quantification of Avascular Areas and Neovascular
Tuft Areas
Quantification of the avascular areas and neovascular tuft
areas in P17 OIR retinas was performed according to a de-
scribed protocol.21 After the injections of the different agents
into P17 OIR eyes, the retinas were flat-mounted and stained
with fluorescein-labeled isolectin B4 (1:150 dilution; Vector
Laboratories, Burlingame, CA). The retinas were photo-
graphed under a fluorescent microscope (BZ-9000; KEY-
ENCE) and merged to obtain whole-mount retinal images
using image-joint software BZ-Analyzer (KEYENCE).
Statistical Analyses
All results are expressed as the means±standard error of the
means. One-way ANOVA followed by Bonferroni t tests was
used to compare the MIP-1b mRNA expression level with
that of the control retinas at each time point. Student’s t-tests
were used to compare the control OIR retinas with those
given MIP-1b Ab. Dunnett’s multiple-comparison tests were
used to compare the areas of avascular retinas and neovas-
cular tufts among groups. Pearson product-moment corre-
lation coefficients were calculated to determine the
correlations between the pathological and physiological NV.
A value of Po0.01 was considered statistically significant.
Statistical analyses were performed using JMP version 7.0.1
(SAS Institute, Cary, NC).
RESULTS
Induction of MIP-1b in OIR Retinas
We have shown that the expression of the MIP-1b gene was
the most upregulated compound in the hypoxic retinas of
mouse OIR mice.1 To confirm the upregulation of the mRNA
and protein levels of MIP-1b in OIR mice, we performed
real-time qRT-PCR and enzyme-linked immunosorbent as-
say (ELISA), respectively, on retinal extracts. Real-time qRT-
PCR showed that the mRNA of MIP-1b was slightly increased
in the retinas of mice 5 days after hyperoxia (P12), and the
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level increased and peaked at 1 day after hypoxia. The level of
the mRNA of MIP-1b then gradually decreased (Figure 1a).
The MIP-1b protein was undetectable until 6 h after the
hypoxic exposure, but markedly increased and peaked on day
2, and then gradually decreased. The protein levels in the P12
control retinas and after 5 days of hyperoxia were below the
detectable level (Figure 1b).
Localization of MIP-1b in OIR Retinas
To determine the location of MIP-1b in the hypoxic retina,
we performed real-time qRT-PCR with extracted mRNA
from the LCM in the GCL, INL, and ONL at each time point.
The mRNA level of MIP-1b was undetectable in each layer of
P12, P12þ 12 h control retinas, and from P12 hyperoxic re-
tinas. At 12 h after relative hypoxia, the mRNA of MIP-1b
was detected in OIR retinas, and the gene expression was
prominent in the GCL and relatively weak in the ONL
(Figure 2). These findings indicated that the expression of the
mRNA of MIP-1b was upregulated in the hypoxic retina and
increased in the inner layer in a hypoxic gradient.
To confirm the sites of the MIP-1b protein in the hypoxic
retina, immunohistochemistry was performed on hypoxic
and normoxic P14 retinas. Signals were observed in the hy-
poxic inner retina and most strongly in the GCL. The cells
located in the INL showed relatively weak signals (Figure 3a).
In contrast, only very weak signals were observed in the GCL
of normal retinas (Figure 3b). As a positive control,
immunoreactivity for VEGF-A, the representative hypoxia-
induced protein in retina, was performed. Consistent with
earlier studies,22 VEGF-A signals were observed in all layers
of both control and hypoxic retinas, but especially strongly in
the hypoxic inner retina (Figure 3c and d).
CCR5 Expression in BM-MLC Infiltrating OIR Retinas
To determine the distribution and morphology of monocyte
lineage cells that were recruited by MIP-1b into the OIR
retinas, immunofluorescent staining for F4/80 combined
with FITC-dextran angiography was performed. In the whole
mounts of P17 OIR retinas, amoeboid F4/80þ cells pos-
sessing thin filopodia-like processes, called ‘activated micro-
glias’,23 and round-shaped F4/80þ cells, monocyte lineage
cells, were detected at the border between vascular and
avascular areas (Figure 4a). A few F4/80þ cells were also
seen in the avascular area.
To confirm the presence of MIP-1b-inducible BM-derived
F4/80þ cells, immunofluorescent staining for F4/80, CCR5,
and CD45 was performed. The round-shaped F4/80þ cells
distinctly coexpressed CCR5 (Figure 4b–d). In contrast, the
signal for CCR5 was negative in most of the amoeboid F4/
80þ cells, but seen weakly in suborbicular cells with short
processes that appeared to be differentiating from monocytes
to amoeboid microglias (arrowhead, Figure 4b–d). Expres-
sion of CD45 was seen in the F4/80þ round-shaped or
suborbicular cells with short processes (Figure 4e–g). Ag-
gregates of round-shaped CCR5þ cells (Figure 4h) and
CD45þ cells (Figure 4i) were seen in P17 OIR retinas, and
Figure 1 Kinetics of the changes in the mRNA (a) and protein levels (b) of
MIP-1b in oxygen-induced retinopathy (OIR) retinas. The mRNA of MIP-1b is
slightly but not significantly increased in the retinas of mice 5 days after
hyperoxia (P12). The level then increases significantly, peaks at 1 day after
the hypoxia and then gradually decreases (a). The protein level of MIP-1b is
undetectable until 6 h after hypoxia but is then markedly increased and
peaks at day 2, and then gradually decreased (b). *Po0.01 compared with
normal subjects.
Figure 2 Expression levels of MIP-1b mRNAs in the retinal ganglion cell
layer (GCL), inner nuclear layer (INL), and outer nuclear layer (ONL) of P12
and P12þ 12-h control retinas, OIR P12 hyperoxic retinas, and OIR retinas at
12 h after hypoxia. The relative level of mRNA expression is quantified and
normalized to the levels of GAPDH mRNA expression. The MIP-1b mRNA
level was undetectable in all layers of both P12, P12þ 12-h control retinas
and P12 hyperoxic retinas. At 12 h after relative hypoxia, the mRNA of MIP-
1b was detected in the OIR retinas, and the distribution of the gene
expression was prominent in the GCL and relatively low in the ONL.
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the merged images showed that most of the cells expressed
both (Figure 4j). These data suggest that CCR5, the sole re-
ceptor for MIP-1b ligand, was expressed in the BM-MLC
infiltrating the P17 OIR retinas.
Blockade of MIP-1b Inhibits F4/80þ Cells Infiltration
into OIR Retinas
To determine whether MIP-1b was involved in the recruit-
ment of monocyte lineage cells into OIR retinas, we ex-
amined whether neutralization of MIP-1b can reduce the
number of F4/80þ round-shaped or suborbicular cells and
the mRNA expression of F4/80 in the P17 OIR retinas. In the
P17 OIR flat-mounted retinas exposed to neutralizing Abs
against MIP-1b, the F4/80þ round-shaped or suborbicular
cells were decreased significantly more than in the retinas
injected with control nonimmune IgG (26.8% decrease,
n¼ 8, Po0.05; Figure 5a–e). In agreement, real-time qRT-
PCR also showed a significant reduction in F4/80 mRNA
Figure 3 Immunohistochemical staining for MIP-1b and VEGF-A in the hypoxic OIR retinas. Signals are observed in the hypoxic inner retina and most
strongly in the GCL, and the cells located in the INL showed relatively weak signals (a). In contrast, only a very weak signal is observed in the GCL of the
normal retina (b). The signal of VEGF-A is observed in all layers of both control and hypoxic retinas (c, d). a and c, retina 2 days after hypoxia (P14); b and d,
control normal retina (P14). Original bar¼ 50 mm.
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Figure 5 Results of quantification of F4/80þ cells and F4/80 mRNA level in P17 OIR retinas. MIP-1b-neutralizing Ab was injected at P12 and P14. At P17, the
whole retinas were immunofluorescently stained with F4/80. The low-power views (a, b) provide perspective, and the square box regions are shown in
the higher magnification views (c, d). Compared with retinas from mice treated with vehicle (a, c), retinas from mice treated with the Ab had fewer
F4/80þ cells (b, d). Image analysis confirmed that there were significantly fewer F4/80þ cells (e, n¼ 8) in retinas from eyes treated with the Ab than
fellow eyes treated with vehicle. Quantitative real-time PCR for F4/80 mRNA expression normalized to GAPDH showed significantly fewer in P17 OIR retinas
treated with the Ab than fellow eyes treated with vehicle (f, n¼ 6). *Po0.01.
Figure 4 CCR5 expression in BM-MLCs infiltrating the P17 OIR retinas. Amoeboid microglias and round-shaped monocyte lineage cells are located at
the border between vascular and avascular areas (a). The round-shaped F4/80þ cells (arrows) and the suborbicular F4/80þ cells with short processes
(arrow head) coexpress CCR5 (b–d). The round-shaped F4/80þ cells or suborbicular F4/80þ cells with short processes coexpress CD45 (e–g).
The round-shaped CCR5þ cells coexpress CD45 (h–j).
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expression in the retinas exposed to Abs compared with the
control P17 OIR retinas (45.7% decrease, n¼ 6, Po0.05;
Figure 5f). These results indicated that MIP-1b has a role in
the infiltration of F4/80þ cells into OIR retinas.
Blockade of MIP-1b Suppresses Physiological
Revascularization and Promotes Pathological NV in
OIR Retinas
To examine the role played by MIP-1b in hypoxia-induced
retinal NV, we tested the effects of neutralizing Abs against
MIP-1b in the physiological revascularization and patholo-
gical NV in the OIR model. We measured the avascular areas
representing physiological revascularization and the areas of
neovascular tufts representing pathological NV in P17 OIR
flat-mounted retinas given Abs against MIP-1b. To com-
pensate for the difference in retinal growth among mice, we
divided the number of pixels in the areas by the number of
pixels in the total retinal area according to the protocol of
Connor.21
The relative sizes of both the avascular areas and the areas
of neovascular tufts were significantly increased. These
findings indicated that the physiological revascularization
was suppressed and pathological NV was enhanced in the
retinas injected with the Abs compared with the control OIR
retinas (34.5 and 21.4% increase, respectively, n¼ 8; Figure
6a, b, d, e, g, and h).
Area of Neovascular Tufts Significantly Correlated with
Area of Avascular Retina, Regardless of Extent of
BM-MLC Infiltration into OIR Retinas
In P17 OIR retinas exposed to neutralizing Abs against MIP-
1b, the size of both the avascular areas and neovascular tufts
significantly increased compared with the control OIR re-
tinas. We then determined the correlation between the sizes
of the avascular areas to that of the neovascular tufts to de-
termine the contribution of hypoxic avascular retinas to the
formation of pathological NV. A very strong correlation was
found both in the control OIR retinas (r¼ 0.953, n¼ 8,
Po0.01) and the retinas injected with the neutralizing Abs
against MIP-1b (r¼ 0.944, n¼ 8, Po0.01; Figure 7a and b).
These results indicated that the formation of pathological NV
strongly depended on the spread of the avascular area, re-
gardless of the extent of BM-MLC infiltration induced by
MIP-1b.
VEGF-A Upregulation has an Important Role in
Promotion of Pathological NV in OIR Retinas
It is well known that hypoxia-induced angiogenic factor
VEGF-A has an important role in the pathogenesis of is-
chemic retinal neovascular diseases, such as diabetic retino-
pathy and branch retinal vein occlusion.9 To examine if
VEGF-A could contribute to the MIP-1b suppression-in-
duced pathological NV enhancement, we investigated the
degree of expression of VEGF-A in the retinas after inhibiting
MIP-1b. The VEGF-A mRNA expression was significantly
increased in the P17 OIR retinas exposed to the neutralizing
Abs against MIP-1b compared with the control OIR retinas
(79.3% increase, Po0.05, n¼ 6; Figure 6i).
Additional intravitreal injections of anti-VEGF-A-neu-
tralizing Abs with anti-MIP-1b Abs did not increase the
sizes of the avascular areas (10.9% increase, n¼ 8, P40.01;
Figure 6g) but significantly decreased the sizes of neovascular
tufts (80.4% decrease, n¼ 8, Po0.01; Figure 6h) compared with
the control OIR retinas. No significant correlation was found
between the sizes of the avascular areas and those of neovascular
tufts in the retinas treated with both Abs (Figure 7c).
These data suggest that the spread of the hypoxic avascular
retina by MIP-1b-inhibition-induced VEGF-A upregulation
results in the promotion of pathological NV.
DISCUSSION
To the best of our knowledge, this is the first study that
showed that the MIP-1b/CCR5 system was involved in the
recruitment of BM-MLCs that promote the physiological
revascularization of hypoxic avascular retinas. The involve-
ment of BM-MLCs in physiological revascularization is in
agreement with earlier studies that BM-derived cells con-
tribute to the growth of blood vessels during postnatal vas-
cular regeneration and vascular remodeling after injury.24,25
In the CNS, BM-MLCs and activated microglias can be
seen at the border of cerebral infarcted areas in the ischemic
brain,26 as we observed at the border between vascular and
avascular retina (Figure 4a). The cells in the cerebral ischemic
areas may secrete a variety of proinflammatory cytokines,27
neurotrophic factors, and angiogenic factors such as VEGF.28
This would then indicate that the BM-MLC-activated mi-
croglias may be involved in the pathogenesis of postischemic
inflammation and subsequent NV in hypoxic retinas.
We observed that the levels of the mRNA and proteins of
MIP-1b were significantly increased shortly after the avas-
cular retinas were exposed to relative hypoxia and then gra-
dually decreased (Figure 1). The kinetics of these changes is
fairly consistent with the size of the central avascular area,
which was at a maximum between P12 and P13 and gradually
decreased due to revascularization.29 In ischemic retino-
pathies, the inner retina, which is supplied by retinal vessels,
is hypoxic whereas the outer retina, which is supplied by the
choroidal vessels, is not.30 Microdissection-based quantitative
analysis and immunohistochemistry showed that the levels of
the mRNAs and protein of MIP-1b increased in the inner
retina in accordance with the hypoxic gradient (Figures 2 and
3). These results clearly demonstrated that MIP-1b is differ-
entially induced both temporally and spatially by retinal
hypoxia. Moreover, higher MIP-1b mRNA expression is
associated with more F4/80þ cells in the region of the
vitreoretinal interface of P14 OIR retinas.31 This distribution
of the F4/80þ cells is reasonable because the physiological
revascularization of hypoxic avascular retina starts from
the superficial vascular plexus between the avascular and
peripheral vascularized areas.32
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The expression of CCR5, the sole receptor for MIP-1b,
appeared to be decreased with activation in the hypoxic re-
tina signal (Figure 4b–d). This finding is in line with the
results of an earlier study by Bosco et al,33 who showed that
hypoxia inhibits the expression of CCR5 in mouse macro-
phages in vitro. They proposed that the downregulation of
CCR5 might represent a negative feedback mechanism that
regulates leukocyte recruitment at the sites of inflammation,
or an important regulatory mechanism to retain/concentrate
recruited macrophages within the lesions by preventing their
migration along other chemokine gradients. On the basis of
the similarity of the mechanisms, the CCR5 expressing BM-
MLCs recruited by MIP-1b secreted from hypoxic retinas
may possibly be retained in the region by downregulating
CCR5, and subsequently activating and exerting angiogenic
activities.
Figure 6 Results of quantification of the avascular areas and neovascular tufts in P17 OIR retinas. Representative images of a flat-mounted OIR retina
(a, d), OIR retina administered with MIP-1b-neutralizing Ab (b, e), and OIR retina coadministered with MIP-1b- and VEGF164-neutralizing Ab (c, f).
The red shading represents neovascular tufts and white shading represents avascular area. In the retinas with MIP-1b Ab, the relative sizes of both the
avascular areas and those of neovascular tufts significantly increased compared with the control OIR retinas (g, h, n¼ 8). In the retinas coadministered with
MIP-1b and VEGF164 Ab, the relative sizes of the avascular areas slightly increased (g, n¼ 8, not significant) and those of neovascular tufts significantly
decreased compared with the control OIR retinas (h, n¼ 8). Quantitative real-time PCR for VEGF-A mRNA expression normalized to GAPDH significantly
increased in P17 OIR retinas with MIP-1b Ab than fellow eyes treated with vehicle (i, n¼ 6). *Po0.05, **Po0.01.
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We have found that MIP-1b is involved in the recruitment
of BM-MLCs into OIR retinas by showing that MIP-1b in-
duces the infiltration of F4/80þ round-shaped or sub-
orbicular cells, which were positive for CD45, a marker
commonly used to identify BM-derived cells. Our finding
that MIP-1b released from hypoxic retina recruited BM-
MLCs is in line with the in vitro chemotaxis assay showing
that MIP-1b cells can induce the migration of blood
monocytes.34 Other members of the chemokine family, such
as MCP-1 and SDF-1/CXCR4, have been reported to regulate
BM-MLC trafficking in hypoxic retinas and the subsequent
pathological NV.15,35 However, the relationship between the
diverse hypoxia-induced chemokines, trafficking properties
of the BM-MLCs, and the variety of biological functions in
hypoxic retinas are not fully understood. It is also known that
VEGF contributes to the recruitment of monocytes to hy-
poxic tissues.36 Thus, it might be possible that the MIP-1b
inhibition and VEGFA upregulation is a compensatory me-
chanism for the decrease of BM-MLC infiltration into OIR
retinas.
Inhibition of BM-MLC infiltration had adverse effects on
the two types of hypoxia-induced retinal NV, a suppression of
physiological revascularization and promotion of pathologi-
cal NV (Figure 6). These results are in accordance with a
recent study demonstrating the contradictory roles of BM-
derived cells in physiological and pathological NV, using the
OIR model with irradiation-induced leukocyte depletion.37
We proposed a mechanism that this apparent contradictory
role is due to the spread of avascular area subsequent to the
suppression of physiological revascularization that has much
stronger effects on the pathological NV compared to that of
BM-MLC infiltration (Figure 7). It is well known that hy-
poxic retinas alter pathological NV as shown by the strong
relationship between the degree of retinal avascularity and
pathological NV in the rat model of OIR.38 In addition, it has
been reported that VEGF-A is an important hypoxia-induced
proangiogenic factor promoting pathological NV.22,39 We
also confirmed that VEGF-A was upregulated in the hypoxic
retina, and that anti-VEGF-A-neutralizing Abs almost com-
pletely suppressed the pathological NV in the OIR retinas
with broad avascular areas caused by the MIP-1b inhibition
(Figure 6).
Taken together, our results showed that the inhibition of
BM-MLC infiltration by the inhibition of MIP-1b suppressed
the physiological revascularization of the avascular area, re-
sulting in the expansion of the hypoxic avascular retina. The
expansion of the hypoxic avascular retina increased the se-
cretion of angiogenic VEGF and consequently promoted
pathological NV. The results of pathological NV promotion
induced by MIP-1b inhibition raise the possibility that, in the
process of preretinal pathological NV, the direct proangio-
genic contribution of BM-MLCs recruited by MIP-1b is very
small. These cells might have an antiangiogenic role, which is
supported by an earlier report, showing the involvement of
macrophages/microglia in pathological NV regression
through apoptosis.35
The current therapeutic approaches for ocular neovascular
diseases mainly focus on inhibiting the pathological NV with
antiangiogenic compounds such as VEGF inhibitors and
angiostatic steroids. In addition, laser photocoagulation of
hypoxic retinal tissue with the idea of causing the regression
of pathological NV, as the ischemic drive is decreased, is also
being used. Promoting physiological revascularization by the
modulation of MIP-1b in the hypoxic avascular retina during
the early phase of ischemic retinopathy might be a new
therapeutic method to prevent the vessel loss and retinal
hypoxia, thereby suppressing subsequent pathological NV in
hypoxia-induced vision-threatening retinal diseases.
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Figure 7 Correlation between the sizes of avascular areas and those of
neovascular tufts in P17 OIR retinas. A very strong correlation was found
both in control OIR retinas (a, n¼ 8) and the retinas injected with the
neutralizing Abs against MIP-1b (b, n¼ 8). The correlation between the
retinas exposed to both MIP-1b- and VEGF164-neutralizing Ab was not
significant (c, n¼ 8).
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